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Abstract 
Background: Several evidences indicate that hormones and neuropeptides function as immunomodulators. Among 
these, growth hormone (GH) is known to act on the thymic microenvironment, supporting its role in thymocyte dif-
ferentiation. The aim of this study was to evaluate the effect of GH on human thymocytes and thymic epithelial cells 
(TEC) in the presence of laminin.
Results: GH increased thymocyte adhesion on BSA-coated and further on laminin-coated surfaces. The number 
of migrating cells in laminin-coated membrane was higher in GH-treated thymocyte group. In both results, VLA-6 
expression on thymocytes was constant. Also, treatment with GH enhanced laminin production by TEC after 24 h in 
culture. However, VLA-6 integrin expression on TEC remained unchanged. Finally, TEC/thymocyte co-culture model 
demonstrated that GH elevated absolute number of double-negative (CD4−CD8−) and single-positive CD4+ and 
CD8+ thymocytes. A decrease in cell number was noted in double-positive (CD4+CD8+) thymocytes.
Conclusions: The results of this study demonstrate that GH is capable of enhancing the migratory capacity of human 
thymocytes in the presence of laminin and promotes modulation of thymocyte subsets after co-culture with TEC.
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Background
Leukocytes differentiate from multipotent cells in the 
bone marrow known as hematopoietic stem cells (HSCs). 
T cells fully maturate in thymus gland, a primary lym-
phoid organ that is involved in the differentiation of these 
cells [1]. The organization of thymic stroma provides spe-
cialized niches that ensure appropriate development of T 
cell progenitors [2]. This microenvironment comprises 
distinct cell types, including thymic epithelial cells (TEC), 
dendritic cells, macrophages and fibroblasts. Moreover, 
such tridimensional cellular organization is intermingled 
with an extracellular matrix (ECM)-containing network 
[3].
Progenitor cells enter the thymus through blood ves-
sels at the cortico-medullary junction and migrate across 
different thymic regions, from the subcapsular cortex to 
deep cortex, toward the medulla, where they differenti-
ate [4]. During this migration, thymocytes interact with 
stromal cells, especially with TEC through cytoplasmic 
projections and membrane receptors [2]. Thymocyte 
maturation is based on a series of intracellular signaling 
events that regulate differentiation, proliferation and cell 
survival [3]. This process may be monitored through the 
presence or absence of cell surface markers such as CD4 
and CD8 glycoproteins. The most immature thymocytes 
do not express CD4 or CD8 and are called double-neg-
ative cells (DN). Following their development, DN cells 
express both CD4 and CD8 to become double-positive 
cells (DP). Finally, upon maturation the cells differenti-
ate into single-positive (SP) thymocytes expressing either 
CD4 or CD8 when they emigrate from the thymus and 
populate the peripheral lymphoid organs [5–7].
It is well established that immune cells secrete and/or 
possess receptors for various hormones, indicating bidi-
rectional communication between the neuroendocrine 
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and immune systems [8]. Growth hormone (GH) is 
one of the first known pituitary peptides that have pro-
found effects on regulation of the immune system in vivo 
through endocrine, paracrine and autocrine mechanisms, 
along with some cytokines [9].
Numerous thymic functions are modulated by GH. 
For example, GH acts on thymocytes, increasing prolif-
eration of these cells and stimulates TEC growth, which 
are essential for T cell differentiation. Furthermore, GH 
increases the production of extracellular matrix mol-
ecules by TEC and secretion of soluble peptides, such 
as cytokines and chemokines, directly involved in intra-
thymic migration of thymocytes and their export to the 
periphery [10–12].
In the last years, effects of GH on thymic cells have 
been studied, however many points need to be clarified. 
In this study, we investigated the in vitro role of GH on 
adhesive and migratory capacities of human thymocytes. 
Furthermore, laminin production and VLA-6 integrin 
expression were assessed on TEC after GH-treatment. 
Finally, thymocyte subsets were examined after contact 
with TEC (co-culture) in the presence of GH.
Results
GH enhances thymocyte adhesion on substrates
In the context of thymocyte differentiation inside thymus 
gland, these cells interact directly with ECM, receiving 
signals to maturation. Thus, thymocytes adhere to these 
molecules, utilizing membrane receptors, and this adhe-
sion is induced or impaired for various hormones [13].
To examine whether thymocyte adhesion on ECM-
composed substrata was modified by GH treatment, 
these cells were allowed to adhere for 1 h in Petri dishes 
coated with laminin or BSA. It was observed that on 
BSA substrate, GH increases number of adhered thy-
mocytes. On laminin substrate, number of adhered cells 
was greater than that on BSA substrate, and GH was 
able to further stimulate thymocyte adhesion on laminin 
(Fig.  1a). When investigating expression of VLA-6, a 
laminin receptor, on adhering cells, it was found that 
adhered thymocytes in the presence of GH had same 
expression levels of this integrin as adhered cells in the 
absence of GH (Fig. 1b).
Thymocyte migration through laminin is improved by GH
Cell migration is a multistep process involving changes in 
the cytoskeleton, cell-substrate adhesions and ECM [14]. 
Once that GH promotes thymocyte adhesion, mainly on 
laminin, it was evaluated whether GH modulates thy-
mocyte migration on transwell inserts. After cell migra-
tion for 3 h, it was found that GH maintains thymocyte 
migration at normal rates. However, on laminin coating, 
the number of migrating cells in GH-treated group was 
higher than the control (Fig.  2a). Nevertheless, it was 
observed that expression of VLA-6, in both situations, 
was unchanged (Fig. 2b).
Increased production of laminin by GH‑treated TEC
Next assessments were focused on human TEC and its 
laminin production after GH treating, since they are 
major cell type of the thymus and the main source of 
ECM molecules [13]. Thus, an immunocytochemistry 
assay was performed. Qualitative analysis showed that 
GH treatment increased laminin production (Fig.  3a). 
This was confirmed, quantitatively, by fluorescence inten-
sity, which demonstrated a significant increase in laminin 
accumulation (Fig. 3b).
Considering the differences observed in laminin pro-
duction patterns, the membrane expression of the 
laminin receptor was evaluated in TEC after exposure to 
GH. The expression of VLA-6 on TEC was essentially the 
same in control versus GH-treated groups (Fig. 3c).
GH promotes modulation in thymocyte subsets 
after co‑culture with TEC
ECM proteins, such as laminin, have been shown to 
actively contribute to the interaction of developing T 
cells with the thymic epithelium during the intrathymic 
migration of thymocytes. Moreover, thymocyte/TEC 
interaction is also a two-way process in which the func-
tioning of TEC is dependent on the influence of thymo-
cytes [15]. For this propose, human thymocyte subsets 
after contact with TEC were evaluated in a co-culture 
model in vitro, and the contribution of GH to the modu-
lation of thymocyte subsets was examined. Fresh thymo-
cytes were added on the TEC monolayer, with or without 
GH, and analyzed after 24  h to determine the absolute 
numbers of all thymocyte subsets.
Dotplots were first obtained to demonstrate the total 
number of thymocytes and the percentage of cells in 
each thymocyte subset (double-negative, double-posi-
tive, CD4+ single-positive and CD8+ single-positive), as 
shown in Fig. 4a. Absolute cell numbers were then com-
pared between the control and GH-treated groups. The 
numbers of double-negative (CD4−CD8−) thymocytes 
were increased after contact with TEC in the presence of 
GH. This effect also was observed in the mature subsets, 
CD4+ single-positive and CD8+ single-positive thymo-
cytes. Interestingly, double-positive (CD4+CD8+) thy-
mocytes showed reduced cell numbers in the GH-treated 
group (Fig. 4b).
Discussion
The thymus is an organ for T cell differentiation and 
selection. Developing thymocytes migrate across the 
thymus to undergo positive and negative selection in 
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the cortex and medulla, respectively. In these migration 
process, several events occur which thymocytes adhere 
to their surrounding ECM and various types of stromal 
cells within the thymus. These stromal cells produce 
ECM, including laminin, which mediates cell–cell con-
tact [16]. Laminin is a heterotrimer of alpha, beta and 
gamma chains. Combinations of five α-, four β- and three 
γ-chains give rise to at least 16 different laminin isoforms 
in mammals. Laminin isoforms can drive numerous pro-
cesses in cells, including cell adhesion, differentiation, 
proliferation, survival/apoptosis and migration. All these 
biological processes require the participation of integrins, 
which are the major receptors for ECM proteins [17]. In 
addition to these intrinsic factors, it is known that the 
thymus is a target of neuroendocrine control through the 
expression of many types of receptors for hormones and 
neuropeptides, which act in endocrine, paracrine and 
autocrine manners. In this aspect, GH exerts pleiotropic 
actions on the thymic microenvironment [18].
In this study, it was demonstrated that some activi-
ties of human thymocytes and TEC are modulated by 
GH. These findings are consistent with previous studies 
obtained in murine models from other groups and of our 
group [19–21]. To promote its effects on thymic cells, 
the molecule binds to GH receptor present on TEC and 
thymocyte surface [22]. It was found that GH stimulates 
human thymocytes to adhere on BSA substrate and also 
on laminin, in which this adhesive capacity is even more 
Fig. 1 GH promotes thymocyte adhesion to laminin. Thymocytes were exposed to GH (100 ng/mL) for 1 h and were then allowed to adhere 
on BSA or laminin substrata. a Absolute number of adhered cells, revealing that GH increases the number of adhered thymocytes on BSA and 
laminin substrata (n = 6/group). b Representative histograms demonstrate VLA-6 expression on thymocytes after 1 h of adhesion (n = 6/group). 
Filled curves represent cells positive for VLA and white curve represents the Ig isotype control. Values are expressed as mean ± SEM. *p ≤ 0.05 and 
***p < 0.001
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pronounced. These events did not change VLA-6 expres-
sion on adhered thymocytes. It has been described [12] 
that thymocytes obtained from GH-Tg and GH-injected 
BALB/c mice adhere in higher numbers onto laminin 
than thymocytes from wild-type mice. Nevertheless, 
membrane levels of laminin receptor VLA-6 on thymo-
cytes did not change. Thus, our results extend actions of 
GH, with respect to the adherence of human thymocytes 
to laminin substrate, and demonstrate that the presence 
of this hormone also stimulates cell adhesion to a generic 
substrate (BSA).
Regarding the unchanged VLA-6 expression, Vielkind 
et  al. [23] conceptualize that integrins have low activity 
in resting cells but can be stimulated to mediate adhesion 
in response to chemokines and cytokines. These stimuli 
induce a process of “inside-out” signaling that is typi-
cally associated with increased avidity of the integrin 
by its ligand (as the result of clustering of receptors and 
their greater lateral mobility) and increases its affinity. 
Our results demonstrate that exposure of thymocytes to 
GH does not alter expression of VLA-6 integrin on the 
plasma membrane. However, as referenced above, it is 
not enough to check the number of receptors on cell sur-
face, but is necessary to analyze activation state and avid-
ity of these molecules. Since cells with high numbers of 
receptors can have them in the resting state, even a small 
number of active receptors on the membrane can gener-
ate evident cellular responses.
Fig. 2 GH improves thymocyte migration through laminin-coating. After 3 h of migration in BSA or laminin-coated transwell. a Absolute number of 
migrant cells, indicating that GH increases thymocyte migration on laminin substrate. b Representative histograms demonstrate VLA-6 expression 
on thymocytes after migration. Filled curves represent VLA positive cells and white curve represents Ig the isotype control. Values are expressed as 
mean ± SEM, n = 6 *p ≤ 0.05
Page 5 of 9Lins et al. Biol Res  (2016) 49:37 
Cell migration is a complex process that involves 
many variables. For instance, egress of single-positive 
cells from thymus to periphery requires that cells must 
be responsive to signals from blood and secondary lym-
phoid organs. To respond to these stimuli, varied gene 
expression of chemokine receptors, adhesion molecules, 
cell signaling molecules and cytoskeletal reorganiza-
tion is necessary. Therefore, a number of changes are 
essential for cell migration [24]. GH has been previously 
implicated in migration of several types of immune cells, 
including human monocytes [25] and resting or activated 
human T cells [26]. Furthermore, GH has ability to serve 
as a chemotactic signal for macrophages and stimulate 
their migration in vitro [27].
In this study, GH positively modulated human thy-
mocyte migration on laminin substrate, but not on BSA 
substrate. It raises the notion that the general effect of 
GH on thymocyte migration results, at least, from a 
combined action of ECM in addition to chemokines and 
other soluble factors in thymus. In murine thymocyte 
transmigration, GH only increases the number of migrat-
ing cells when combined with CXCL12 chemokine, but 
no alteration in thymocyte migration is observed after 
GH treatment individually, suggesting that this hormone 
enhances sensitivity of these cells to migratory stimuli, as 
well on substrata (in this case, laminin) that are needed 
for cell migration [28]. The fact that cell migration is 
stimulated further when GH is combined with laminin is 
consistent with the observations of Yanagawa et al. [29], 
who demonstrate that chemotactic activity of stromal 
cell-derived factor-1α (SDF-1α) is considerably and selec-
tively enhanced in the presence of laminin.
Thymic microenvironment is composed mainly by epi-
thelial cells, which form a meshwork to provide mechani-
cal support and stimuli for proliferation and development 
of thymocytes. Moreover, macrophages, dendritic cells, 
fibroblasts and extracellular matrix constitute this network 
[13, 30]. TEC produces soluble thymocyte modulators 
including thymic hormones and cytokines. Addition-
ally, TEC/thymocyte interactions occur through classical 
Fig. 3 Laminin production by TEC after GH-treatment. TECs were plated in labtek chamber slides, treated with GH (100 ng/mL) for 24 h and then 
analyzed by fluorescence microscopy. a Photomicrographs show the production of laminin ascertained by immunofluorescence and fluorescence 
microscopy analysis. b Bars correspond to the quantitative analysis of laminin production in TEC in selected microscopic fields. Results are expressed 
as pixels/μm2. GH-treated cells increase laminin deposition. c Cytofluorometric profiles of TEC immunolabeled with anti-CD49f mAb, which defines 
the alpha chain of integrin VLA-6, the main receptor for laminin. Filled curves represent positive cells for VLA and white curve represents the Ig 
isotype control. Values correspond to mean ± SEM of three independent experiments, **p ≤ 0.01
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adhesion molecules. TEC can bind and interact with 
maturing thymocytes by extracellular matrix ligands and 
respective receptors. Laminin is distributed heterogene-
ously within thymic parenchyma, being produced by TECs 
[13]. Our results showed augmented production of laminin 
by TEC after GH-treatment. This finding corroborates 
the idea that this network of epithelial cells is controlled 
by extrinsic circuits such as neuroendocrine axis. For 
instance, the augmentation of ECM expression as seen, not 
only in cultures of TEC lines, but also in primary cultures 
of epithelial cells derived from isolated thymic nurse lym-
phoepithelial complexes [11], and in mice overexpressing 
GH (GH-Tg) that exhibit enhanced laminin deposition in 
cortical and medullary regions of thymic lobules [12].
Fig. 4 Modulation of thymocyte subsets by GH-treatment and after contact with TEC. At the end of 24 h of contact with TEC in the presence or 
absence of GH, thymocytes were recovered and stained with CD4/CD8 mAbs, fixed, and analyzed by flow cytometry. In a viable thymocytes were 
selected and quadrants were used to individualize subsets, showing the cell percentage in each. In b bars show the absolute numbers of CD4/
CD8-defined thymocyte subsets. GH induced distinct modulation in subsets, increasing CD4−CD8−, CD4+ and CD8+ subsets, and decreasing the 
CD4+CD8+ subset. Results are expressed as mean ± SEM (n = 6/group). *p ≤ 0.05 and **p ≤ 0.01
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Considering these effects of GH on human thymocytes 
and TEC separately, we observed its effects on TEC/thy-
mocyte co-culture. In this assay, we demonstrated two 
main aspects. First, as shown by immunocytochemis-
try, GH stimulates laminin production by TEC, and this 
phenomenon is directly related to thymocyte adhesion 
and migration, as shown by our initial results. Thus, GH 
contributes to intrathymic differentiation that occurs 
concomitantly with thymocyte adhesion and migration 
through thymic stroma [18]. The second observation is 
fluctuation in subsets, which is displayed after 24  h of 
contact with TEC, in the presence of GH.
We hypothesize that GH may act indirectly promot-
ing secretion of interleukin-7 (IL-7) by TEC. GH may 
act directly upon immune tissues or its effects may be 
mediated indirectly through insulin-like growth factor-1 
(IGF-1) [8, 9]. Reduced serum concentration of IL-7, 
smaller thymic volume and diminished output of naive 
T-lymphocytes observed in GH deficiency children sug-
gest that thymic function may be impaired in the pres-
ence of defective GH production. In these children, GH 
deficiency was associated with a pattern of impaired syn-
chronous release of GH and IGF-1 [31]. Furthermore, 
GH treatment enhances circulating levels of IGF-1 and 
IL-7 of HIV-1–infected adults. These findings suggest 
that IGF-1 occupies an important role in GH-mediated 
enhancement of T cell production and offer fundamental 
insight into the mechanism of GH effects on the human 
immune system [32]. More recently, IGF-1, a proximal 
mediator of the metabolic action of GH, was found to 
induce expression and release of IL-7 in cultured human 
thymic epithelial cells [33].
The role of IL-7 in thymopoiesis is multifaceted, pro-
moting thymocyte proliferation and survival by upregu-
lating anti-apoptotic protein Bcl-2 and downregulating 
pro-apoptotic protein Bax [34]. GH can modulate genes 
committed to distinct biological activities of thymic epi-
thelial cells, including expression of this cytokine [35].
IL-7 receptor is expressed on DN thymocytes but is 
downregulated in DP thymocytes and is restored after 
positive selection, when thymocytes complete differen-
tiation process (SP thymocytes) [36]. DN and both SP 
subsets thymocytes were responsive to IL-7 and DP 
population responded poorly [37]. If TEC increases 
IL-7 secretion because of GH treatment, these thymo-
cyte subsets (DN, CD4+SP and CD8+SP) would dis-
play increased proliferation, which would explain their 
higher absolute number, whereas the numbers of DP 
thymocytes decreases in comparison to control group.
Considering all these data, we suggest that GH has 
pleiotropic effects on lymphoid (thymocytes) and 
non-lymphoid (TEC) compartments of thymus, thus 
corroborating with physiology of this organ in supply-
ing T cells to the organism. This study also contributes 
to current information about effects of GH on human 
thymic cells, which is important when proposing GH-
based therapies for the recovery of the immune system.
Conclusions
These results point that GH is involved in adhesive and 
migratory capacity of human thymocytes and modu-
lates production of laminin by TEC, without altering 
VLA-6 expression on both cells. Furthermore GH posi-
tively increases absolute number of double-negative 
(CD4−CD8−) thymocytes and single-positive CD4+ and 
CD8+ thymocytes after co-culture with TEC in vitro. In 
this context, considering that GH has been used as an 
adjuvant therapeutic agent in immunodeficiencies, these 
data presented herein provide background knowledge for 
future GH-based immunotherapy interventions.
Methods
Reagents and antibodies
Recombinant human GH was purchased from Dong-A 
Pharmaceutical Co., Ltd (Dalseong-Gun, Daegu, South 
Korea). Laminin 111 protein, primary anti-laminin anti-
body and secondary goat anti-rabbit-FITC conjugated 
antibody were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Monoclonal antibodies: anti-CD4 allophy-
cocyanin (APC), anti-CD8 peridinin chlorophyll protein 
(PerCP), anti-CD49f phycoerythrin (PE) and rat IgG2a 
PE were purchased from eBioscience (San Diego, CA, 
USA). Fetal bovine serum (FBS), RPMI-1640 medium, 
l-glutamine, gentamicin, Trypsin–EDTA, phosphate 
buffered saline (PBS) and bovine serum albumin (BSA) 
were obtained from Sigma-Aldrich.
Cells and culture conditions
Human thymic fragments were obtained from children 
(aged 1  day to 9  years) undergoing corrective cardiac 
surgery at Santa Casa de Misericórdia Hospital. Tissue 
was minced, large aggregates were removed by passing 
through a nylon mesh and thymocytes in suspension 
were kept in RPMI-1640 supplemented with 10 % heat-
inactivated FBS, 1  % l-glutamine and 40  mg/mL gen-
tamicin, at 4  °C before the experiments. All procedures 
were approved by the ethics committee on research of 
UFAL by protocol number 028370/2010-07.
Human thymic epithelial cell line (TEC), generated 
from explants of a postnatal organ [38], was utilized in 
this study. Cell cultures were grown in a complete RPMI-
1640 medium, at 37 °C in a humidified 5 % CO2 atmos-
phere. Passage of cells by trypsin–EDTA treatment was 
performed after every 3–4 days.
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Thymocyte adhesion assay
To assess thymocyte adhesive capacity, 6-well culture 
plates were coated for 1  h at room temperature with 
10  µg/mL laminin or BSA as a control. In these assays, 
1 × 107 fresh thymocytes were allowed to adhere on sub-
strata for 1 h, in the presence or absence of GH (100 ng/
mL) and 3 mL RPMI/FBS 2 %, at 37 °C. After removal of 
non-adherent thymocytes by PBS washing, adherent thy-
mocytes were harvested with cool PBS, counted and ana-
lyzed by flow cytometry.
Thymocyte migration assay
Thymocyte migratory activity was evaluated using a 
transwell system (6.5-mm diameter, 5-μm pore size, 
polycarbonate membrane) (Corning Costar, Cambridge, 
MA, USA) using cell suspensions. In this chemot-
axis assay, membranes were coated on both sides with 
10 µg/mL laminin or BSA for 1 h at 37 °C, followed by 
1 h of blocking with 1 % BSA. Thymocytes (2.5 × 106) 
in 100  µL 0.5  % BSA/RPMI 1640 with or without GH 
(100  ng/mL) were then added to the upper chamber, 
and 600 µL 0.5  % BSA/RPMI 1640 was added to the 
lower chamber. After 3 h of incubation at 37  °C in 5 % 
CO2-containing air, cells migrated into the lower cham-
bers and were removed, counted and analyzed by flow 
cytometry.
Cytofluorometry
Thymocyte suspensions in PBS with 4 % FBS were incu-
bated with a mixture of appropriate dilutions of the 
following mAb: anti-CD4/APC, anti-CD8/PerCP, anti-
CD49f/PE, as well as, isotype-matched negative controls 
for each fluorochrome. Cells were stained for 20 min at 
4 °C, fixed with PBS/Formaldehyde 2 % and analyzed by 
flow cytometry on FACSCanto II (BD Biosciences). A 
gate excluding cell debris and nonviable cells was applied 
using forward versus side scatter parameters pre-estab-
lished for thymocytes. Analysis with FACSDiva software 
(BD Biosciences) was performed after recording 10,000–
50,000 events for each sample.
TEC were grown in 6-well plate (3  ×  105 cells/well) 
and treated with GH (100  ng/mL) for 24  h, in 500  µL 
RPMI/FBS 2  %. Cells were recovered by scraping and 
incubated with diluted antibody (anti-CD49f ) or iso-
type-matched negative control. After washing, the cells 
were fixed with PBS/Formaldehyde 2 % and analyzed by 
flow cytometry.
Immunocytochemistry
Human TEC (5 ×  103) were plated in a 8-well Lab-tek 
chamber slides, with complete medium for 16 h to allow 
cell adhesion. The medium was then replaced and cells 
were treated with GH (100 ng/mL). After 24 h, cultures 
were washed with PBS and fixed with methanol, fol-
lowed by incubation with anti-laminin primary anti-
body for 1  h at room temperature, washed with PBS, 
and incubated with goat anti-rabbit-FITC conjugated 
secondary antibody for 45  min at room temperature. 
Immunostained samples were analyzed by fluorescence 
microscopy (Nikon Eclipse 50i; Nikon Instruments Inc., 
Chicago, IL, USA). A negative control with second-
ary antibody was used and did not show any significant 
immunolabeling. Quantitative fluorescence analysis 
were performed by transforming specific staining to pix-
els and by dividing the total pixel numbers by the area 
analyzed, thus obtaining the number of pixels/μm2, 
using the ImageJ software.
TEC/thymocyte co‑culture assay
Co-culture assays were performed in 24-well plates 
at a ratio of 100 thymocytes/TEC. Firstly, 1 ×  104 TEC 
were plated in a well with 500  µL complete RPMI and 
after 16  h of cell adhesion, 1  ×  106 fresh thymocytes 
were plated on the TEC monolayer while replacing the 
medium with 500 µL RPMI/FBS 2 % with or without GH. 
After 24  h of co-culture, thymocytes were recovered, 
counted and analyzed by flow cytometry.
Statistical analysis
The data obtained were analyzed using one-way ANOVA 
followed by Newman-Keuls post-test or by Student’s 
t test and considered as statistically significant when 
p values were  ≤0.05. Values were presented as the 
mean ± standard error of the mean (SEM).
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